当前位置:首页 - 行情中心 - 天新药业(603235) - 财务分析 - 现金流量表

天新药业

(603235)

  

流通市值:40.21亿  总市值:119.69亿
流通股本:1.47亿   总股本:4.38亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,038,942,294.14552,669,525.71,979,653,693.51,426,623,174.06
  收到的税费返还32,510,657.2524,500,064.7744,580,451.0924,228,896.81
  收到其他与经营活动有关的现金19,626,775.8910,810,106.0885,064,026.3569,017,918.88
  经营活动现金流入小计1,091,079,727.28587,979,696.552,109,298,170.941,519,869,989.75
  购买商品、接受劳务支付的现金396,775,058.03195,687,630.9944,264,535.24621,043,260.96
  支付给职工以及为职工支付的现金247,736,143.65159,324,945.23407,114,151.4303,547,141.14
  支付的各项税费81,958,770.7342,275,173.48175,377,914.36121,794,173.05
  支付其他与经营活动有关的现金22,612,055.529,431,007.7282,885,715.4733,632,980.15
  经营活动现金流出小计749,082,027.93406,718,757.331,609,642,316.471,080,017,555.3
  经营活动产生的现金流量净额341,997,699.35181,260,939.22499,655,854.47439,852,434.45
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额17,159.29-266,312.996,100
  收到的其他与投资活动有关的现金3,072,534,586.451,291,300,379.671,756,020,159.661,008,672,562.63
  投资活动现金流入小计3,072,551,745.741,291,300,379.671,756,286,472.651,008,678,662.63
  购建固定资产、无形资产和其他长期资产支付的现金350,955,383.99188,366,271.991,066,956,760.36766,075,027.2
  支付其他与投资活动有关的现金2,744,322,000818,000,4622,230,000,0001,125,000,000
  投资活动现金流出小计3,095,277,383.991,006,366,733.993,296,956,760.361,891,075,027.2
  投资活动产生的现金流量净额-22,725,638.25284,933,645.68-1,540,670,287.71-882,396,364.57
三、筹资活动产生的现金流量:
  取得借款收到的现金202,488,961.1783,516,021.17297,432,594.11270,033,981.82
  收到其他与筹资活动有关的现金6,700,900-14,997,516.17-
  筹资活动现金流入小计209,189,861.1783,516,021.17312,430,110.28270,033,981.82
  偿还债务支付的现金1,000,0001,000,000269,000,000269,000,000
  分配股利、利润或偿付利息支付的现金281,143,071.961,244,966.37220,188,546.56219,738,310.66
  支付其他与筹资活动有关的现金1,710,058.46-63,434,597.9160,004,545.9
  筹资活动现金流出小计283,853,130.422,244,966.37552,623,144.47548,742,856.56
  筹资活动产生的现金流量净额-74,663,269.2581,271,054.8-240,193,034.19-278,708,874.74
四、汇率变动对现金及现金等价物的影响9,695,228.44-944,536.9551,705,671.7138,290,469.57
五、现金及现金等价物净增加额254,304,020.29546,521,102.75-1,229,501,795.72-682,962,335.29
  加:期初现金及现金等价物余额1,078,267,195.811,078,267,195.812,307,768,991.532,307,768,991.53
  期末现金及现金等价物余额1,332,571,216.11,624,788,298.561,078,267,195.811,624,806,656.24
补充资料:
  净利润356,013,549.3-651,223,139.61-
  资产减值准备14,004,087.93-7,542,795.49-
  固定资产和投资性房地产折旧84,746,908.05-146,745,318.72-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧84,746,908.05-146,745,318.72-
  无形资产摊销2,282,689.98-4,509,353.8-
  长期待摊费用摊销918,032.19-1,385,837.04-
  处置固定资产、无形资产和其他长期资产的损失10,296.5--962.33-
  固定资产报废损失49,171.52-1,074,746.02-
  公允价值变动损失-465,538.02--2,238,666.8-
  财务费用-8,991,427.39--49,223,422.46-
  投资损失-4,121,010.46--5,444,358.6-
  递延所得税2,108,248.23--2,050,619.82-
  其中:递延所得税资产减少2,108,248.23--2,050,619.82-
  存货的减少-15,086,943.35--117,199,913.05-
  经营性应收项目的减少25,604,109.12--239,107,515.82-
  经营性应付项目的增加-97,298,977.93-128,491,580.49-
  其他-18,182,262.18--32,418,037.92-
  不涉及现金收支的投资和筹资活动金额其他项目--0-
  现金的期末余额1,332,571,216.1-1,078,267,195.81-
  减:现金的期初余额1,078,267,195.81-2,307,768,991.53-
  现金及现金等价物的净增加额254,304,020.29--1,229,501,795.72-
公告日期2025-08-292025-04-302025-04-262024-10-30
审计意见(境内)标准无保留意见
TOP↑